These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 11958767)

  • 1. [Tetrabamate and a benefit-risk ratio].
    Isabel Lucena M; Andrade RJ; García-Ruiz E; Madurga M
    Med Clin (Barc); 2002 Apr; 118(12):477. PubMed ID: 11958767
    [No Abstract]   [Full Text] [Related]  

  • 2. [Tetrabamate in the treatment of agoraphobia].
    Iruela Cuadrado LM; García Páez JM
    Med Clin (Barc); 1988 Nov; 91(18):717. PubMed ID: 3230993
    [No Abstract]   [Full Text] [Related]  

  • 3. [Double-blind study of the efficacy of tetrabamate and tiapride in the treatment of alcohol deprivation syndrome].
    Santo Domingo Carrasco J; Bravo Ortiz MF; Barroso Cañizares A; Caballero Martín L
    Med Clin (Barc); 1985 Oct; 85(13):533-6. PubMed ID: 3908847
    [No Abstract]   [Full Text] [Related]  

  • 4. [Anxiolytic efficacy and tolerance of tetrabamate in anxious patients abusing alcohol. Multicenter double-blind versus placebo study].
    Lôo H; Guelfi JD; Malka R; Brion S; Cottin M; Gailledreau J; Raab A; Salfati M; Sarda A; Godchau M
    Encephale; 1986; 12(5):291-7. PubMed ID: 3545785
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [A controlled double-blind study of tetrabamate versus lorazepam and placebo in generalized anxiety].
    Lôo H; Malka R; Hantouche E; Lancrenon S; Guelfi JD
    Encephale; 1991; 17(4):295-300. PubMed ID: 1959498
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Double blind study on the efficacy and safety of tetrabamate and chlordiazepoxide in the treatment of the acute alcohol withdrawal syndrome.
    Radouco-Thomas S; Garcin F; Guay D; Marquis PA; Chabot F; Huot J; Chawla S; Forest JC; Martin S; Stewart G
    Prog Neuropsychopharmacol Biol Psychiatry; 1989; 13(1-2):55-75. PubMed ID: 2664886
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Acute liver failure following tetrabamate].
    Binder D; Jost R; Flury R; Salomon F
    Schweiz Med Wochenschr; 1995 May; 125(19):965-9. PubMed ID: 7761807
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Tetrabamate-induced hepatotoxicity. Report of seven cases and literature review].
    López-Torres E; Lucena MI; Andrade RJ; García Ruiz E; Fernández MC; Peláez G; Soria de la Cruz MJ; Pizarro A
    Gastroenterol Hepatol; 2002 Dec; 25(10):589-93. PubMed ID: 12459120
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Use of Atrium 300 in the withdrawal of alcoholic patients].
    Fontan M; Taine D
    Therapeutique; 1973; 49(7):463-6. PubMed ID: 4595358
    [No Abstract]   [Full Text] [Related]  

  • 10. [Treatment of the psychosyndrome of alcoholic withdrawal using Atrium].
    Descloux A
    Rev Med Suisse Romande; 1971 Jan; 91(1):57-62. PubMed ID: 5164795
    [No Abstract]   [Full Text] [Related]  

  • 11. [Anxiolytic agents in alcoholism].
    Rodríguez-Martos A
    Aten Primaria; 1994 Mar; 13(5):260-4. PubMed ID: 7654926
    [No Abstract]   [Full Text] [Related]  

  • 12. [A double blind comparative study of atrium 300 and heminiurine in chronic alcoholics].
    Teijeiro J
    Med Hyg (Geneve); 1975 Oct; 33(1164):1441-2. PubMed ID: 768722
    [No Abstract]   [Full Text] [Related]  

  • 13. [A comparative double-blind study of atrium 300 and hemineurine in chronic alcoholics (author's transl)].
    Teijeiro J
    Schweiz Rundsch Med Prax; 1976 Apr; 65(14):420-2. PubMed ID: 981161
    [No Abstract]   [Full Text] [Related]  

  • 14. [The test of serum GGT decrease after alcoholic withdrawal. Study in 221 patients treated with Atrium].
    Latrive JP; Lemoine JP; Forget P
    Therapie; 1987; 42(2):246-7. PubMed ID: 2887044
    [No Abstract]   [Full Text] [Related]  

  • 15. [Severe acute hepatitis caused by Atrium].
    Brocheriou I; Zafrani ES; Mavier P
    Gastroenterol Clin Biol; 1993; 17(4):305-6. PubMed ID: 8339895
    [No Abstract]   [Full Text] [Related]  

  • 16. [Atrium-induced hepatitis with autoimmune pattern].
    Pariente EA; Mineur D
    Gastroenterol Clin Biol; 1992; 16(5):485-6. PubMed ID: 1526409
    [No Abstract]   [Full Text] [Related]  

  • 17. [When drug withdrawal for safety concerns may be harmful. A case report with tetrabamate].
    Raveloarimisy L; Gras-Champel V; Lemaire-Nanni E; Burde-Hamm F; Andréjak M; Guilbaud JC
    Therapie; 2002; 57(6):593-5. PubMed ID: 12666269
    [No Abstract]   [Full Text] [Related]  

  • 18. [Stevens-Johnson syndrome induced by tetrabamate in a patient with HIV infection].
    Lleonart R; Nomdedeu J; Sambeat MA
    Med Clin (Barc); 1992 Oct; 99(12):474. PubMed ID: 1460902
    [No Abstract]   [Full Text] [Related]  

  • 19. [Acute hepatitis associated with microvesicular steatosis induced by Atrium].
    Schneider S; Charles F; Chichmanian RM; Montoya ML; Rampal P
    Gastroenterol Clin Biol; 1995 Dec; 19(12):1064-5. PubMed ID: 8729422
    [No Abstract]   [Full Text] [Related]  

  • 20. [Use of 5-butyl-1-cyclohexyl-2,4,6,-trioxoperidropyrimidine (BCP) in the prevention and therapy of neonatal hyperbilirubinemia. Comparative study with phenobarbital].
    Centa A; Camera G; Piccinini A; De Pietro P; Tomatis C
    Minerva Pediatr; 1976 Apr; 28(15):911-21. PubMed ID: 11400
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.